|
C9ORF6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.042600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.726600E-01 |
| Normal-vs-Stage2 |
5.697000E-01 |
| Normal-vs-Stage3 |
9.949600E-01 |
| Normal-vs-Stage4 |
1.272430E-01 |
| Stage1-vs-Stage2 |
4.373000E-01 |
| Stage1-vs-Stage3 |
7.640200E-01 |
| Stage1-vs-Stage4 |
6.311500E-02 |
| Stage2-vs-Stage3 |
5.805200E-01 |
| Stage2-vs-Stage4 |
2.947200E-01 |
| Stage3-vs-Stage4 |
6.891900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.886600E-01 |
| Normal-vs-AfricanAmerican |
4.474400E-01 |
| Normal-vs-Asian |
9.771600E-01 |
| Caucasian-vs-AfricanAmerican |
5.040400E-01 |
| Caucasian-vs-Asian |
9.487400E-01 |
| AfricanAmerican-vs-Asian |
7.637000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.204600E-01 |
| Normal-vs-Female |
2.507800E-01 |
| Male-vs-Female |
1.618030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.972600E-01 |
| Normal-vs-Extreme_Weight |
3.952600E-01 |
| Normal-vs-Obese |
4.567000E-01 |
| Normal-vs-Extreme_Obese |
6.676000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.905000E-01 |
| Normal_Weight-vs-Obese |
4.089600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.015200E-01 |
| Extreme_Weight-vs-Obese |
1.962380E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.670000E-01 |
| Obese-vs-Extreme_Obese |
5.284400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.286000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.693700E-02 |
| Normal-vs-Age(61-80Yrs) |
3.316000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.612800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.527000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.145000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.709200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.499000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.968200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.727800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.399400E-01 |
| Normal-VS-Type2 PRCC |
4.417400E-01 |
| Normal-VS-KIRP CIMP |
9.670200E-02 |
| Normal-VS-Unclassified PRCC |
9.099800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.456170E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.698390E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.666000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.047180E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.664000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.614210E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.081200E-01 |
| Normal-vs-N1 |
3.682000E-02 |
| Normal-vs-N2 |
8.359000E-01 |
| N0-vs-N1 |
3.158600E-03 |
| N0-vs-N2 |
4.852200E-01 |
| N1-vs-N2 |
5.171400E-01 |
|
|
